Compare TFII & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TFII | AXSM |
|---|---|---|
| Founded | 1957 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.4B |
| IPO Year | N/A | 2015 |
| Metric | TFII | AXSM |
|---|---|---|
| Price | $103.25 | $183.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 20 |
| Target Price | $112.90 | ★ $176.75 |
| AVG Volume (30 Days) | 280.4K | ★ 590.3K |
| Earning Date | 02-18-2026 | 02-17-2026 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.89 | N/A |
| Revenue | ★ $8,047,566,000.00 | $561,263,000.00 |
| Revenue This Year | N/A | $66.40 |
| Revenue Next Year | $2.77 | $56.13 |
| P/E Ratio | $26.04 | ★ N/A |
| Revenue Growth | N/A | ★ 65.83 |
| 52 Week Low | $72.02 | $79.19 |
| 52 Week High | $140.35 | $184.40 |
| Indicator | TFII | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 79.34 |
| Support Level | $104.62 | $148.14 |
| Resistance Level | $106.91 | $158.56 |
| Average True Range (ATR) | 1.99 | 5.59 |
| MACD | -0.45 | 1.60 |
| Stochastic Oscillator | 22.75 | 96.98 |
TFI International Inc is involved in the provision of transportation and logistics services across the United States, Canada, and Mexico. The company's reportable segments are; Less-Than-Truckload, which derives maximum revenue, Truckload, and Logistics. The Less-Than-Truckload segment engages in pickup, consolidation, transport, and delivery of smaller loads; the Truckload segment deals with full loads carried directly from the customer to the destination using a closed van or specialized equipment to meet customers' specific needs; and the Logistics segment provides asset-light logistics services, including brokerage, freight forwarding, and transportation management, as well as small package parcel delivery. Geographically, the company generates maximum revenue from the United States.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.